TY  - JOUR
A1  - Bias, Harald
A1  - Quarcoo, David
A1  - Meier-Wronski, Claus
A1  - Wicker, Sabine
A1  - Seybold, Joachim
A1  - Nienhaus, Albert
A1  - Groneberg, Jan David Alexander
A1  - Roux, Andrés de
T1  - Self-reported adverse reactions in 4337 healthcare workers immunizations against novel H1N1 influenza
T2  - BMC Research Notes
N2  - Purpose: The use of the 2009 H1N1 vaccine has generated much debate concerning safety issues among the general population and physicians. Therefore, we investigated the safety of an inactivated monovalent H1N1 pandemic influenza vaccine Methods: We focused on the H1N1 pandemic influenza vaccine Pandemrix(R) and applied a self reporting questionnaire in a population of healthcare workers (HCWs) and medical students at a major university hospital. Results: In total, 4337 individuals were vaccinated, consisting of 3808 HCWs and 529 medical students. The vaccination rate of the employees was higher than 40%.The majority of individuals were vaccinated in November 2009. In total, 291 of the 4337 vaccinations were reported to lead to one or more adverse reactions (6.7%). Local reactions were reported in 3.8%, myalgia and arthralgia in 3.7%, fatigue in 3.7%, headache in 3.1%. Conclusions: Our data together with available data from several national and international institutions points to a safe pandemic influenza vaccine.
KW  - adverse reaction
KW  - healthcare worker
KW  - immunization
KW  - novel H1N1 influenza
Y1  - 2011
UR  - http://publikationen.ub.uni-frankfurt.de/frontdoor/index/index/docId/22686
UR  - https://nbn-resolving.org/urn:nbn:de:hebis:30-113568
SN  - 1756-0500
N1  - © 2011 Groneberg et al; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
VL  - 4
IS  - 297
SP  - 1
EP  - 6
PB  - Biomed Central
CY  - London
ER  -